The US drug company, Novavax, reviewed its preliminary data and said on Monday that its vaccine appears to be about 90% effective. With the rise of transmissible variants, more vaccine options are critical in the pandemic. The main global vaccine initiative, COVAX, has faced delays as wealthy countries secured the majority of doses.
The story you just read is available for free because thousands of listeners and readers like you generously support our nonprofit newsroom. Every day, reporters and producers at The World are hard at work bringing you human-centered news from across the globe. But we can’t do it without you: We need your support to ensure we can continue this work for another year.
Make a gift today, and you’ll get us one step closer to our goal of raising $25,000 by June 14. We need your help now more than ever!